-
EP3863604
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3863604
| EP3863604 - OROMUCOSAL SOLUTIONS OF ZOLPIDEM OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 08.08.2024 Database last updated on 19.10.2024 | |
| Former | Grant of patent is intended Status updated on 28.04.2024 | ||
| Former | Examination is in progress Status updated on 24.02.2023 | ||
| Former | Request for examination was made Status updated on 16.07.2021 | ||
| Former | The international publication has been made Status updated on 18.04.2020 | ||
| Former | unknown Status updated on 01.11.2019 | Most recent event Tooltip | 08.08.2024 | (Expected) grant | published on 11.09.2024 [2024/37] | Applicant(s) | For all designated states Troikaa Pharmaceuticals Limited Commerce House- 1 Satya Marg Bodakdev Ahmedabad 380054 GUJ / IN | [2021/33] | Inventor(s) | 01 /
PATEL, Nisheel K. Troikaa Pharmaceuticals Limited Commerce House 1, Satya Marg Bodakdev, Ahmedabad 380054 / IN | 02 /
PATEL, Ketan R. Troikaa Pharmaceuticals Limited Commerce House 1, Satya Marg Bodakdev, Ahmedabad 380054 / IN | 03 /
PATEL, Milan R. Troikaa Pharmaceuticals Limited Commerce House 1, Satya Marg Bodakdev, Ahmedabad 380054 / IN | 04 /
PATEL, Kush M. Troikaa Pharmaceuticals Limited Commerce House 1, Satya Marg Bodakdev, Ahmedabad 380054 / IN | 05 /
PATEL, Asheel K. Troikaa Pharmaceuticals Limited Commerce House 1, Satya Marg Bodakdev, Ahmedabad 380054 / IN | [2021/33] | Representative(s) | Engstle, Verena Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB Bankgasse 3 90402 Nürnberg / DE | [2021/33] | Application number, filing date | 19790867.6 | 04.10.2019 | [2021/33] | WO2019IN50734 | Priority number, date | IN201821038060 | 08.10.2018 Original published format: IN201821038060 | [2021/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020075183 | Date: | 16.04.2020 | Language: | EN | [2020/16] | Type: | A1 Application with search report | No.: | EP3863604 | Date: | 18.08.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.04.2020 takes the place of the publication of the European patent application. | [2021/33] | Type: | B1 Patent specification | No.: | EP3863604 | Date: | 11.09.2024 | Language: | EN | [2024/37] | Search report(s) | International search report - published on: | EP | 16.04.2020 | Classification | IPC: | A61K9/00, A61K9/08, A61K31/437, A61P25/20 | [2021/33] | CPC: |
A61K9/006 (EP,IL,KR);
A61K9/08 (EP,IL,KR,US);
A61K31/437 (EP,IL,KR,US);
A61K47/02 (US);
A61K47/10 (KR,US);
A61K47/14 (US);
A61K47/26 (US);
A61K47/32 (KR,US);
A61K47/38 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/33]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | OROMUKOSALE LÖSUNGEN VON ZOLPIDEM ODER PHARMAZEUTISCH ANNEHMBAREN SALZEN DAVON | [2021/33] | English: | OROMUCOSAL SOLUTIONS OF ZOLPIDEM OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | [2021/33] | French: | SOLUTIONS OROMUQUEUSES DE ZOLPIDEM OU SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CELLES-CI | [2021/33] | Entry into regional phase | 19.04.2021 | National basic fee paid | 19.04.2021 | Designation fee(s) paid | 19.04.2021 | Examination fee paid | Examination procedure | 19.04.2021 | Examination requested [2021/33] | 19.04.2021 | Date on which the examining division has become responsible | 01.12.2021 | Amendment by applicant (claims and/or description) | 27.02.2023 | Despatch of a communication from the examining division (Time limit: M04) | 05.07.2023 | Reply to a communication from the examining division | 29.04.2024 | Communication of intention to grant the patent | 06.08.2024 | Fee for grant paid | 06.08.2024 | Fee for publishing/printing paid | 06.08.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 28.10.2021 | Renewal fee patent year 03 | 27.10.2022 | Renewal fee patent year 04 | 30.10.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XDY]WO2005032519 (NOVADEL PHARMA INC [US], et al); | [YD]WO2005079761 (TRANSORAL PHARMACEUTICALS INC [US], et al); | [XD]WO2008141264 (NOVADEL PHARMA INC [US], et al) | by applicant | WO9916417 | WO2005032519 | WO2005079761 | WO2006046041 | WO2006128022 | WO2007123955 | WO2008141264 |